MedTrace Logo

The Role of the Human Microbiome in Patients After Pancreatic Resection.

NCT06381882 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-04-27

No results posted yet for this study

Summary

The goal of this observational study is to classify patients that undergo pancreatic resection for presumed pancreatic or periampullary malignancy into high and low risk groups for postoperative complications based on longitudinal saliva, rectal/faecal, tumor, blood and/or bile microbiome profiles.

To identify the dynamics of the microbiome, as well as the possibly related short-term and long-term complications, multiple samples at different timepoints are needed from the patients.

Conditions

  • Pancreas Cancer
  • Pancreas Neoplasm
  • Pancreas Adenocarcinoma
  • Periampullary Cancer
  • Periampullary Carcinoma
  • Microbial Colonization

Interventions

PROCEDURE

Pancreatic resection

Any kind of pancreatic resection will be included

Sponsors & Collaborators

  • St. Antonius Hospital

    lead OTHER

Principal Investigators

  • Robert Verdonk, dr. · St. Antonius Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2026-08-01
Completion
2026-11-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06381882 on ClinicalTrials.gov